Metastatic Castration-Resistant Prostate Cancer Patients
6 clinical trials · Condition
◉ Watch Metastatic Castration-Resistant Prostate Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®) (NCT03643107) | Allarity Therapeutics | 2018-10-17 |
| Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program (NCT01786031) | Gustave Roussy, Cancer Campus, Grand Paris | 2012-12-01 |
Track Metastatic Castration-Resistant Prostate Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.